![](/pharma/pharma_may19/contents/526201/1_Esketamine_content.480_0_1.jpg)
A form of ketamine for use as a treatment for depression is exciting interest
![](/pharma/pharma_may19/contents/526202/2_EMA_content.400_0_1.jpg)
The EMA is lowering the flag of its London base and moving to the Netherlands
![](/pharma/pharma_may19/contents/526203/3_cannabis_content.480_0_1.jpg)
Exploring the potential of the medical cannabis market in the UK
![](/pharma/pharma_may19/contents/526204/4_open_content.480_0_1.jpg)
Putting aside profits and patent protection in favour of greater collaboration
![](/pharma/pharma_may19/contents/526205/5_memory_content.480_0_1.jpg)
Meet the innovative treatments helping researchers to fight memory loss
![](/pharma/pharma_may19/contents/526206/6_RUNLABS_content.480_0_1.jpg)
RUNLABS: providing flexible lab space to help new biotech firms find their feet